25
Participants
Start Date
November 18, 2021
Primary Completion Date
March 7, 2024
Study Completion Date
March 7, 2024
VIT-2763 120 mg
"Participants receive 2 capsules of VIT-2763 30 mg in the morning and in the evening, for 8 weeks.~Capsules are to be taken orally."
VIT-2763 360 mg
"Participants receive 2 capsules of VIT-2763 60 mg in the morning, in the afternoon and in the evening for 8 weeks.~Capsules are to be taken orally."
VIT-2763 240 mg
"Participants receive 2 capsules of VIT-2763 60 mg in the morning and in the evening, for 8 weeks.~Capsules are to be taken orally."
Placebo BID
"Participants receive 2 capsules of placebo in the morning and in the evening, for 8 weeks.~Capsules are to be taken orally."
Placebo TID
"Participants receive 2 capsules of Placebo in the morning, in the afternoon and in the evening, for 8 weeks.~Capsules are to be taken orally."
Investigator Site 305, Athens
Investigator Site 701, Greenville
Investigator Site 711, Charleston
Investigator Site 706, Hollywood
Investigator Site 702, Milwaukee
Investigator Site 703, Chicago
Investigator Site 713, Aurora
Investigator Site 708, Los Angeles
Investigator Site 801, Colombes
Investigator Site 802, Lyon
Investigator Site 709, Birmingham
Investigator site 301, Athens
Investigator Site 302, Pátrai
Investigator Site 101, Baabda
Investigator Site 102, Beirut
Investigator Site 103, Tripoli
Investigator Site 601, London
Investigator Site 605, London
Investigator Site 606, Liverpool
Investigator Site 603, London
Investigator Site 608, London
Investigator Site 607, Manchester
Collaborators (1)
Fortrea
INDUSTRY
Vifor (International) Inc.
INDUSTRY